Travere Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	78.36	93.04	58.54	58.18	61.69	165.75
Short-Term Investments	186.31	229.76	312.17	508.68	388.56	387.13
Cash & Short-Term Investments	264.68	322.8	370.7	566.85	450.25	552.88
Cash Growth	-17.86%	-12.92%	-34.60%	25.90%	-18.56%	52.90%
Accounts Receivable	87.3	80.13	27.12	21.18	16.65	15.91
Total Trade Receivables	87.3	80.13	27.12	21.18	16.65	15.91
Inventory	30.7	30.28	35.66	31.49	4.52	7.31
Other Current Assets	34.35	28.76	12.69	19.34	15.02	6.72
Total Current Assets	392.68	437.57	416.7	616.78	486.44	582.83
Net Property, Plant & Equipment	13.3	14.6	19.63	25.54	30.05	34.3
Other Intangible Assets	110.04	113.87	103.97	104.44	97.07	148.44
Other Long-Term Assets	8.48	8.88	18.16	10.66	59.03	11.07
Total Assets	555.19	605.19	594.13	788.91	672.59	776.63
Accounts Payable	12.91	24.8	23.53	41.68	17.29	15.14
Accrued Expenses	104.41	126.04	86.03	118.99	95.74	75.18
Current Portion of Long-Term Debt	-	-	68.68	-	-	-
Current Portion of Leases	6.02	5.88	5.41	4.91	4.43	3.91
Unearned Revenue	-	-	-	7.1	11.98	16.27
Other Current Liabilities	2.1	3.19	17.11	5.24	12.72	13.59
Total Current Liabilities	125.44	159.9	200.75	177.91	142.16	124.09
Long-Term Debt	312.08	311.72	310.31	377.26	375.55	226.58
Long-Term Leases	9.57	11.13	17.19	22.61	27.51	31.5
Other Long-Term Liabilities	9.38	7.6	6.8	10.32	84.52	92.36
Total Long-Term Liabilities	331.02	330.46	334.3	410.2	487.57	350.43
Total Liabilities	456.46	490.36	535.05	588.1	629.73	474.52
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,610	1,589	1,506	1,328	1,060	1,069
Accumulated Other Comprehensive Income	-1.06	-1.19	-0.08	-1.46	-2.91	-0.56
Retained Earnings	-1,510	-1,473	-1,447	-1,126	-1,014	-765.97
Shareholders' Equity	98.73	114.83	59.08	200.81	42.85	302.11
Total Liabilities & Equity	555.19	605.19	594.13	788.91	672.59	776.63
Total Debt	327.66	328.73	401.58	404.78	407.49	261.99
Net Cash (Debt)	-62.99	-5.94	-30.88	162.07	42.76	290.9
Net Cash Growth	-	-	-	279.04%	-85.30%	147.45%
Net Cash Per Share	-0.67	-0.07	-0.39	2.18	0.67	4.86
Book Value	98.73	114.83	59.08	200.81	42.85	302.11
Book Value Per Share	1.06	1.29	0.75	2.70	0.67	5.05
Tangible Book Value	-11.31	0.96	-44.9	96.37	-54.22	153.68
Tangible Book Value Per Share	-0.12	0.01	-0.57	1.30	-0.85	2.57

Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q